Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

A rabbit with sebaceous adenitis was effectively treated with ciclosporin and medium-chain triglycerides.

JAK inhibitors show promise for treating various skin diseases.

LEKTI is crucial for skin barrier and immune function, affecting conditions like Netherton syndrome and atopic dermatitis.

New molecules can prevent cell death in hair follicles.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

Cepharanthine could be a strong antiviral against COVID-19.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

Shh and Dhh affect skin development and can cause tumors, while Ihh does not.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Sdr16c5 and Sdr16c6 genes regulate a key point in lipid production that affects eye and skin gland function.

Lack of TG2 increases fat storage and lowers cell cleanup in skin oil cells.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

Entospletinib effectively prevents eye and skin GVHD in mice.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

A boy with a rare skin condition and kidney disease improved with cyclosporine after steroids failed, suggesting a new treatment approach.

Oleoylethanolamide (OEA) safely boosts fat production in skin cells and may help treat dry skin and reduce inflammation.

Cepharanthine shows promise as a potential lung cancer treatment by effectively killing cancer cells.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

JAK inhibitors show promise for treating skin diseases effectively and safely.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

New compounds show promise as nonsteroidal treatments for hair loss.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

The HG3 hair gel is the most effective for treating seborrheic dermatitis.